News

The Pharma Letter22m
Pathos AI lands $365 million for AI-driven cancer drugs
Pathos AI, a US biotech specializing in artificial intelligence for cancer drug development, has raised $365 million in a ...
The Pharma Letter49m
Therini Bio raises additional $39 million Series A financing
US clinical-stage biotech Therini Bio yesterday revealed that it raised $39 million in a Series A extension financing, which ...